Philip D. Lister
Department of Medical Microbiology and Immunology
Creighton University School of Medicine
2500 California Plaza
Omaha
USA
Name/email consistency: high
- Antibacterial-resistant Pseudomonas aeruginosa: clinical impact and complex regulation of chromosomally encoded resistance mechanisms. Lister, P.D., Wolter, D.J., Hanson, N.D. Clin. Microbiol. Rev. (2009)
- Pharmacodynamics of levofloxacin against characterized ciprofloxacin-resistant Streptococcus pneumoniae. Lister, P.D. Postgrad. Med (2008)
- Carbapenems in the USA: focus on doripenem. Lister, P.D. Expert. Rev. Anti. Infect. Ther (2007)
- The role of pharmacodynamic research in the assessment and development of new antibacterial drugs. Lister, P.D. Biochem. Pharmacol. (2006)
- Levofloxacin/imipenem prevents the emergence of high-level resistance among Pseudomonas aeruginosa strains already lacking susceptibility to one or both drugs. Lister, P.D., Wolter, D.J., Wickman, P.A., Reisbig, M.D. J. Antimicrob. Chemother. (2006)
- Levofloxacin-imipenem combination prevents the emergence of resistance among clinical isolates of Pseudomonas aeruginosa. Lister, P.D., Wolter, D.J. Clin. Infect. Dis. (2005)
- Pharmacodynamics of gatifloxacin against Streptococcus pneumoniae in an in vitro pharmacokinetic model: impact of area under the curve/MIC ratios on eradication. Lister, P.D. Antimicrob. Agents Chemother. (2002)
- Pharmacodynamics of 750 mg and 500 mg doses of levofloxacin against ciprofloxacin-resistant strains of Streptococcus pneumoniae. Lister, P.D. Diagn. Microbiol. Infect. Dis. (2002)
- Chromosomally-encoded resistance mechanisms of Pseudomonas aeruginosa: therapeutic implications. Lister, P.D. Am. J. Pharmacogenomics (2002)
- Pharmacodynamics of moxifloxacin and levofloxacin against Staphylococcus aureus and Staphylococcus epidermidis in an in vitro pharmacodynamic model. Lister, P.D. Clin. Infect. Dis. (2001)
- Pharmacodynamics of moxifloxacin, levofloxacin and sparfloxacin against Streptococcus pneumoniae. Lister, P.D., Sanders, C.C. J. Antimicrob. Chemother. (2001)
- Clavulanate induces expression of the Pseudomonas aeruginosa AmpC cephalosporinase at physiologically relevant concentrations and antagonizes the antibacterial activity of ticarcillin. Lister, P.D., Gardner, V.M., Sanders, C.C. Antimicrob. Agents Chemother. (1999)
- Pharmacodynamics of trovafloxacin, ofloxacin, and ciprofloxacin against Streptococcus pneumoniae in an in vitro pharmacokinetic model. Lister, P.D., Sanders, C.C. Antimicrob. Agents Chemother. (1999)
- Pharmacodynamics of levofloxacin and ciprofloxacin against Streptococcus pneumoniae. Lister, P.D., Sanders, C.C. J. Antimicrob. Chemother. (1999)
- Cefepime-aztreonam: a unique double beta-lactam combination for Pseudomonas aeruginosa. Lister, P.D., Sanders, W.E., Sanders, C.C. Antimicrob. Agents Chemother. (1998)